Home » Topics » BioWorld Science

BioWorld Science
RSS

Revised Remicade label strengthens warnings about risk of infections

Aug. 27, 2001

Study of Cytran's IM-862 in ovarian cancer begins at Magee-Womens Hospital

Aug. 27, 2001

Lilly and Isis establish antisense strategic alliance

Aug. 27, 2001

Enrollment for study of Zadaxin in hepatitis B in Japan completed

Aug. 27, 2001

Biomira and Merck KGaA to meet with FDA regarding Theratope vaccine

Aug. 27, 2001

Visudyne approved for additional ocular conditions in the U.S.

Aug. 27, 2001

Ivax announces encouraging phase I results of BNP-166 as treatment of Crohn's disease

Aug. 27, 2001

Novogen to initiate clinical trial of oral phenoxodiol in advanced prostate cancer

Aug. 27, 2001

Chrysalis reports positive trends from pilot Chrysalin clinical trial for diabetic ulcers

Aug. 27, 2001

Immunex and Wyeth-Ayerst to commence longitudinal rheumatoid arthritis study

Aug. 27, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...